[1]
“Influence of Leukotriene Pathway Polymorphisms (Arachidonate 5-lipoxygenase ALOX5,Cysteinyl Leukotriene Receptor CysLTR1) On Response to Montelukast in A sample of Asthmatic Iraqi Patients”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 193–198, Oct. 2022, doi: 10.47750/pnr.2022.13.04.024.